Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 8/20 | 0.48 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 3/20 | 0.36 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5311339 | 0.80 | CYP19A1 (0.41) | CYP19A1MBOAT4SHBGNR1I3CYP17A1 | |
| SCHEMBL5310607 | 0.80 | ALDH1A1 (0.41) | CYP19A1SHBGNR1I3CYP17A1 | |
| SCHEMBL5309770 | 0.79 | AR (0.32) | CYP19A1SHBGCYP17A1 | |
| SCHEMBL5308811 | 0.79 | CYP19A1 (0.47) | CYP19A1MBOAT4SHBGNR1I3CYP17A1 | |
| SCHEMBL5310140 | 0.78 | CYP19A1 (0.43) | CYP19A1MBOAT4SHBGNR1I3 | |
| SCHEMBL7523457 | 0.78 | CYP19A1 (0.52) | CYP19A1MBOAT4SHBG | |
| SCHEMBL4448019 | 0.77 | SHBG (0.41) | CYP19A1SHBGCYP17A1 | |
| SCHEMBL5574735 | 0.76 | CYP19A1 (0.39) | CYP19A1SHBG | |
| SCHEMBL3996133 | 0.75 | SHBG (0.44) | CYP19A1SHBGCYP17A1 | |
| SCHEMBL6899628 | 0.75 | GRIN1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1539183-A4 | THERAPEUTIC TREATMENT METHODS | HOLLIS EDEN PHARMACEUTICALS (US) | 2007-04-25 | — | — | EP | claimed |
| EP-1539183-A1 | THERAPEUTIC TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2005-06-15 | — | — | EP | claimed |
| WO-2004019953-A1 | THERAPEUTIC TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2004-03-11 | — | — | WO | claimed |
| EP-1807118-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| EP-1539183-A4 | THERAPEUTIC TREATMENT METHODS | HOLLIS EDEN PHARMACEUTICALS (US) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006110172-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS.INC. (US) | 2006-10-19 | — | — | WO | disclosed |
| EP-1539183-A1 | THERAPEUTIC TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004019953-A1 | THERAPEUTIC TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2004-03-11 | — | — | WO | disclosed |